Hillory J. Farias and Samantha Reid Date-Rape Drug Prohibition Act of 2000

Hillory J. Farias Date-Rape Prevention Drug Act of 1999 - Amends the Controlled Substances Act (CSA) to add gamma hydroxybutyric acid (GHB) to schedule I, ketamine to schedule III, and gamma butyrolactone (GBL) as an additional list I chemical. Provides for a limited exemption from Schedule I manufacturing and distributing facility security requirements for facilities manufacturing and distributing GHB for a Food and Drug Administration (FDA)-approved clinical study, pursuant to the Federal Food, Drug, and Cosmetic Act, in which case Schedule III facility security requirements apply. Places an FDA-approved GHB drug product into Schedule III. Adds Schedule I penalties for the unlawful use of an approved drug product that contains GHB. Specifies that the designation of GBL or any other chemical as a listed chemical under the CSA does not preclude a finding that the chemical is a controlled substance analogue. Includes controlled substance analogues within the scope of provision regarding penalties for distribution of a controlled substance. (Sec. 4) Amends the CSA to authorize the Attorney General to establish specified reporting requirements for GHB products in Schedule III, including annual reports of end-of-year inventories and requirements that dispensing practitioners maintain certain records regarding prescriptions. (Sec. 5) Directs the Attorney General to make a grant for …

Congressional Research Service · 1999-09-27